Adult Vaccines are an essential component of preventive healthcare, offering protection against a range of infectious diseases that can pose serious risks to adults' health and well-being. While often overshadowed by childhood vaccination programs, adult immunization is equally crucial for maintaining individual health and preventing the spread of contagious illnesses within communities. Influenza, commonly known as the flu, is a prime example of a vaccine-preventable disease that affects millions of adults worldwide each year. Annual flu vaccination is recommended for all adults, particularly those at higher risk of complications, such as older adults, pregnant women, and individuals with chronic health conditions.
Another important adult vaccine is the tetanus, diphtheria, and pertussis (Tdap) vaccine. Tetanus, a bacterial infection that affects the nervous system, can be transmitted through wounds or cuts and can lead to severe muscle spasms and respiratory failure. The Tdap vaccine provides protection against tetanus, diphtheria, and pertussis (whooping cough) and is recommended for adults who have not received a Tdap vaccine previously. Human papillomavirus (HPV) vaccine is another critical immunization for adults, particularly for those who may not have been vaccinated during adolescence. Vaccination against HPV can help prevent these cancers and is recommended for adults up to age 45.
Despite the clear benefits of adult vaccination, coverage rates remain suboptimal. Barriers to vaccination include lack of awareness, limited access to healthcare services, and vaccine hesitancy. Public health efforts are needed to increase awareness of the importance of adult immunization, improve access to vaccines, and address misconceptions about vaccine safety and efficacy.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States